Abstract
Why have some countries suppressed waves of the COVID-19 pandemic much more effectively than others? We find that the decay rate of daily cases or deaths from peak levels varies by a factor of ∼40 between countries. This measure of country-level resilience to COVID-19 is positively correlated with trust within society, and with the adaptive increase in stringency of government interventions when epidemic waves occur. All countries where >40% agree “most people can be trusted” achieve a near complete reduction of new cases and deaths. In contrast, countries where governments maintain greater background stringency tend to be less trusting and less resilient. Building trust is therefore critical to resilience, both to epidemics and other unexpected disruptions, of which COVID-19 is unlikely to be the last.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Leverhulme Trust grant RPG-2018-046. Alan Turing Institute fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos